Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
POLICY PAPERS
April 15, 2024
Many low- and middle-income countries are projected to spend less on health over the rest of this decade than they did pre-2020. The adage “more health for the money” is more meaningful than ever—but how do we act on it quickly? Disinvesting from low-value health technologies and interventions is on...
WORKING PAPERS
April 04, 2024
Star firms, defined as the top 10 percentile of firms in the world in terms of return on invested capital, are more likely to occur in high-income countries and manufacturing industry, but there is an increasing share of star firms from middle-income countries and the services sector. Star firms hav...
Blog Post
April 04, 2024
A large academic and policy debate has focused on the increase in market concentration over the past few decades which has given rise to “star firms,” a small set of firms that generate abnormal returns for their investors. A common concern is that these firms exert excess market power and behave as...
Blog Post
March 13, 2024
When world leaders gather in September for this year’s UN General Assembly, antimicrobial resistance (AMR) will be on the agenda. For people like me who care passionately about this issue, this is a welcome opportunity to address a global problem with a global solution. Ahead of September, we need t...
Blog Post
February 26, 2024
As most of the developing world struggles to increase, let alone maintain current levels of domestic health expenditure, getting more health for the money has never been more important. Building robust health technology assessment (HTA) systems to inform governments on which health technologies and ...
Blog Post
February 22, 2024
The process of discovering, producing, buying, and consuming antibiotics is riddled with market and government failures. To solve antibiotic resistance, it’s not enough to solve just some of these. If we fix the market failures that reduce the number of new antibiotics that are discovered, but not t...
WORKING PAPERS
February 22, 2024
Antibiotic resistance (ABR) already contributes to almost five million deaths per year. Without action, this number will likely rise substantially. We provide the first comprehensive assessment of the economic drivers of ABR, arguing that ABR in large part arises from extensive unresolved market (an...
Blog Post
December 06, 2023
Men are the majority customers in bank lending portfolios throughout the world. The gender gap in access to credit is larger in developing countries and especially onerous for women entrepreneurs who suffered disproportionate employment and income losses during the recent COVID pandemic. What drives...
Blog Post
November 09, 2023
There are so many studies regarding so many aspects of development economics that it can be difficult to keep up. Last week was the North East Universities Development Consortium annual conference, often called NEUDC. Researchers presented more than 130 papers across a wide range of topics, from agr...
Blog Post
October 23, 2023
In times of mounting debt, the quest for universal health coverage (UHC) faces critical challenges. Rising debt has far-reaching effects, including reduced access to financing, political instability, and decreased spending on international aid. The burden of debt, coupled with high inflation, is thr...